Fibroblast Growth Factor-23 Is Not a Single Bystander in Chronic Kidney Disease Mortality

被引：1
|
作者：
Pelletier, Solenne [1 ]
Fouque, Denis [1 ]
机构：
[1] Ctr Hosp Lyon Sud, Dept Nephrol, Pierre Benite, Rhone Alpes, France
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2018年 / 29卷 / 10期
关键词：
fibroblast growth factor; klotho; cardiovascular events; hemodialysis; survival; KLOTHO;
D O I：
10.1681/ASN.2018060583
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2601 / 2601
页数：1
相关论文
共 50 条
  • [1] Fibroblast Growth Factor-23 Concentration in Dogs with Chronic Kidney Disease
    Harjes, L. M.
    Parker, V. J.
    Dembek, K.
    Young, G. S.
    Giovaninni, L. H.
    Kogika, M. M.
    Chew, D. J.
    Toribio, R. E.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2017, 31 (03): : 784 - 790
  • [2] The impact of fibroblast growth factor-23 on the cardiovascular system in chronic kidney disease
    Lee, Gavin
    Krishnasamy, Rathika
    Hawley, Carmel M.
    Johnson, David W.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2015, 10 (06) : 565 - 568
  • [3] The association of indoxyl sulfate with fibroblast growth factor-23 in cats with chronic kidney disease
    Liao, Yu-Lun
    Chou, Chi-Chung
    Lee, Ya-Jane
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2019, 33 (02) : 686 - 693
  • [4] A prospective study of fibroblast growth factor-23 in children with chronic kidney disease
    Magnusson, Per
    Hansson, Sverker
    Swolin-Eide, Diana
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2010, 70 (01) : 15 - 20
  • [5] Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease
    Galvao, Joao F. de Brito
    Nagode, Larry A.
    Schenck, Patricia A.
    Chew, Dennis J.
    JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE, 2013, 23 (02) : 134 - 162
  • [6] Fibroblast growth factor 23: associations with cardiovascular disease and mortality in chronic kidney disease
    Negri, Armando Luis
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (01) : 9 - 17
  • [7] Serum osteoprotegerin, RANKL and fibroblast growth factor-23 in children with chronic kidney disease
    Siomou, Ekaterini
    Challa, Anna
    Printza, Nikoleta
    Giapros, Vasileios
    Petropoulou, Fotini
    Mitsioni, Andromachi
    Papachristou, Fotios
    Stefanidis, Constantinos J.
    PEDIATRIC NEPHROLOGY, 2011, 26 (07) : 1105 - 1114
  • [8] Serum troponin-I as a marker of fibroblast growth factor-23 (FGF-23) cardiotoxic effect, in patients with chronic kidney disease
    Taranova, M. V.
    Milovanova, L. Yu.
    Kozlovskaya , L. V.
    Milovanova, S. Yu.
    Androsova, T. V.
    Zubacheva, D. O.
    Lebedeva, M. V.
    Dobrosmyslov, I. A.
    Kozlov, V. V.
    Kuchieva, A. M.
    Li, O. A.
    Reshetnikov, V. A.
    TERAPEVTICHESKII ARKHIV, 2019, 91 (06) : 85 - 92
  • [9] Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study
    Chen, Wei
    Melamed, Michal L.
    Hostetter, Thomas H.
    Bauer, Carolyn
    Raff, Amanda C.
    Almudevar, Anthony L.
    Lalonde, Amy
    Messing, Susan
    Abramowitz, Matthew K.
    BMC NEPHROLOGY, 2016, 17
  • [10] Diabetes Modifies Effect of High-Phosphate Diet on Fibroblast Growth Factor-23 in Chronic Kidney Disease
    Muras, Katarzyna
    Masajtis-Zagajewska, Anna
    Nowicki, Michal
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (12) : E1901 - E1908
12345